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Abstract Optimizing productivity and growth rates of re-
combinant Chinese hamster ovary (CHO) cells requires in-
sight into the regulation of cellular processes. In this regard,
the elucidation of the epigenetic process of DNAmethylation,
known to influence transcription by a differential occurrence
in CpG islands in promoter regions, is increasingly gaining
importance. However, DNA methylation has not yet been
investigated on a genomic scale in CHO cells and suitable
tools have not existed until now. Based on the genomic and
transcriptomic CHO data currently available, we developed a
customized oligonucleotide microarray covering 19598 CpG
islands (89 % of total bioinformatically identified CpG
islands) in the CHO genome. We applied our CHO-specific
CpG island microarray to investigate the effect of butyrate
treatment on differential DNAmethylation in CHO cultures in
a time-dependent approach. Supplementation of butyrate is
known to enhance cell specific productivities in CHO cells
and leads to alterations of epigenetic silencing events. Gene
ontology clusters regarding, e.g., chromatin modification or
DNA repair, were significantly overrepresented 24 h after
butyrate addition. Functional classifications furthermore indi-
cated that several major signaling systems such as the Wnt/β-
catenin pathway were affected by butyrate treatment. Our
novel CHO-specific CpG island microarray will provide valu-
able information in future studies of cellular processes asso-
ciated with productivity and product characteristics.
Keywords Chinese hamster ovary cells . Epigenetics . DNA
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Introduction
More than 200 biopharmaceutical molecules have been pro-
duced by means of mammalian cultivation systems since the
first recombinant protein, tissue plasminogen activator (tPA),
was approved by the FDA in 1986 (Walsh 2010). About 70 %
of these products are made in Chinese hamster ovary (CHO)
cells. They account for the production of seven out of the ten
top-selling biopharmaceuticals in 2011, comprising, e.g.,
Rituxan® (Biogen Idec) or Avastin® (Roche) (Huggett and
Lähteenmaki 2012). Even though CHO cells have been used
extensively over the last three decades, still little is known
about the molecular basis for their versatile properties regard-
ing productivity, robustness and adaptability. Addressing this
problemmore efficiently, the CHO genome and transcriptome
were sequenced in 2011 (Becker et al. 2011; Xu et al. 2011).
The data obtained in this way now enables researchers to
conduct genome-scale analyses investigating regulatory
cellular mechanisms, e.g., the identification of miRNA
gene loci and the respective pre-miRNA sequences by
Hackl et al. (2012).
Among other factors, the transcriptional activity of recom-
binant genes strongly depends on their integration site within
the genome. In many cases such transgenes become rapidly
silenced even if they are integrated into active euchromatin
(Wurm 2004). Those processes are frequently accompanied
by changes in histone modification and DNA methylation
(Mutskov and Felsenfeld 2004; Osterlehner et al. 2011). One
way to inhibit silencing processes of recombinant genes is the
treatment with organic substances such as the short-chain fatty
acid (SCFA) butyrate (Kwaks and Otte 2006). There are,
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however, cytotoxic side effects of butyrate treatment, resulting
in growth inhibition and apoptosis (Zhou et al. 2011; Chang
et al. 2012). Various approaches to diminish the cytotoxic
effects of butyrate treatment have been made, e.g., by com-
bining butyrate treatment with low cultivation temperatures
(Chen et al. 2011) or by repression of apoptotic pathways
(Sung and Lee 2005; Kim et al. 2009). The exact mechanism
of action upon butyrate addition is still unknown, although on
the molecular level butyrate was shown to inhibit histone
deacetylase (HDAC) activity and induce remodeling of chro-
matin structures (Boffa et al. 1978), as well as to enhance, e.g.,
the expression of growth arrest and DNA damage inducible
protein (Gadd45) isoforms (Chen et al. 2002). Gadd45 pro-
teins in turn were shown to contribute to DNA demethylation
by DNA damage repair (Rai et al. 2008). In this context, the
analysis of epigenetic effects — especially on the level of
DNA methylation — represents an important step towards
gaining further insights into the cellular response to butyrate
addition.
In mammals, DNA methylation (the addition of a methyl
group to the C5 position of cytosine residues) predominantly
takes place in the context of CpG dinucleotides (CpGs) and
affects most CpG sites in the genome (Illingworth and Bird
2009). An exception are genomic regions with high CpG
frequencies, so-called CpG islands (CGIs), that are in large
parts unmethylated and associated with promoter regions of
constitutively expressed genes (Ndlovu et al. 2011). Another
subgroup of promoter-associated CGIs shows differential
methylation between cell types or under certain conditions
and can thus be associated with cellular functions (Illingworth
and Bird 2009). Changes of promoter methylation often cor-
relate with transcriptional regulation of the associated gene
(Ndlovu et al. 2011), whereas the methylation status of intra-
genic CGIs may affect different processes. It has been shown
that many protein-coding genes are expressed by using alter-
native promoters in a tissue specific manner and thus
may be regulated by associated intragenic CGIs (Sun
et al. 2011). Methylation of exon–intron boundaries may
moreover correlate with alternative splicing processes
(Kornblihtt et al. 2013). Finally, intragenic CGIs possi-
bly regulate the expression of non-coding RNAs
(ncRNAs) (Sato et al. 2011).
In order to perform genome-wide screenings for differen-
tially methylated CGIs in CHO cells, we developed a micro-
array covering 19598 promoter-associated and intragenic
CGIs. We applied the array to compare butyrate-treated
CHO cultures with untreated references over the course
of a batch cultivation in order to detect changes in
DNA methylation in a time-dependent manner. To our
knowledge, this is the first report in literature on a CGI
microarray from CHO sequence data and an analysis of
the butyrate effect on DNA methylation events in CHO
cells.
Material and methods
Cell culture and cultivation process analysis
Anti IL-8-antibody-producing CHO DP-12 cells (clone
#1934, ATCC CRL-12445) were cultivated in chemically
defined, animal component-free medium CHOMACS® CD
(Miltenyi Biotec, Bergisch Gladbach, Germany) supplement-
ed with 6 mM L-glutamine (Fagron GmbH & Co. KG,
Barsbüttel, Germany) and 200 nM methotrexate (MTX;
Wyeth, Madison, NJ, USA). Insulin-like growth factor was
added to the media in a concentration of 0.1 mg/l (Long R3
IGF-I; Sigma-Aldrich, Munich, Germany). For sample prep-
aration, cells were cultivated in 250-ml shaker flasks (Corning
Inc., Corning, New York, USA) with a culture volume of
70 ml and a seeding cell density of 3×105 cells/ml. Eight
cultures were prepared from one preculture. Culture flasks
were kept at 37 °C, 80 % humidity and 5 % CO2 on a shaking
platform at 185 rpm (50 mm diameter rotation). Three days
after inoculation, 3 mM butyric acid (Sigma-Aldrich) was
added to four cultures. The other four were kept as control
cultures without butyrate addition. Before (0 h), 1 (24 h) and 2
(48 h) days upon butyrate addition, 3×106 cells per culture
were harvested for DNA extraction. Measurements of cell
densities and viabilities were performed on a Cedex AS20
cell counter (Innovatis AG, Bielefeld, Germany). IgG concen-
trations were measured with an HPLC method on protein A
columns according to the manufacturer´s protocol (Poros A;
Applied Biosystems, Foster City, CA, USA).
DNA preparation
Genomic DNAwas prepared by standard phenol chloroform
isoamylalcohol (PCI) extraction (Sambrook and Russell
2006) and extended proteinase K (Carl Roth, Karlsruhe,
Germany) treatment for at least 6 h. Purified DNA was pre-
cipitated with isopropanol. The pellets were dissolved in TE
buffer (10 mM Tris–HCl, 1 mM EDTA) with gentle shaking
for 24 h at 4 °C.
Enrichment of methylated DNA
Genomic DNAwas sonicated to an average fragment size of
500 bp using a Branson Sonifier 450-A (Branson Ultrasonics,
Danbury, CT, USA). Sonication was carried out in TE buffer
for 20 s with 20 % amplitude while cooling the tubes in ice
water, and repeated up to 12 times depending on the persistent
presence of high molecular DNA on agarose TAE control
gels. We used 9 μg of fragmented genomic DNA per culture,
treatment and sampling point for enrichment of methylated
DNA by magnetic beads coupled MBD2-Fc protein (Epimark
Methylated DNA Enrichment Kit; NEB, Ipswich, MA, USA)
according to the manufacturer´s protocol. Eight washing steps
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were used to wash off unbound DNA. After purification with
silica columns, the DNA samples from the four replicate
cultures of each time point were pooled before microarray
analysis.
CpG island microarray analysis
The analysis of differential CGI methylation was carried out
using customized CHO-specific oligonucleotide CGI micro-
arrays. Based on the currently available genomic (Xu et al.
2011) and transcriptomic CHO data (Becker et al. 2011)
promoter-associated and intragenic CGIs were predicted
according to the algorithm of Takai and Jones (2002).
Probes were designed with average distances of 500 bp, in
regard to the average DNA fragment lengths after sonication.
All probes are present at least twice per array, so that exper-
iments with two arrays (including a dye swap) result in 4–6 n
per probe. Customized arrays were printed by Agilent
Technologies in an 8×60K high-density format.
Enriched DNA samples were labeled with Cyanine 3- and
5-dUTP, respectively, using the SureTag DNA Labeling Kit
(Agilent Technologies, Santa Clara, CA, USA) according to
the manufacturer's protocol. For each time point, samples of
treated and reference cultures were labeled as dye swap pairs.
After removal of unincorporated dye and vacuum concentra-
tion, the samples were eluted in 6.3 μl TE buffer.
Subsequently the Cy3- and Cy5-labeled samples were com-
bined and 29 μl of hybridization mastermix (4.3 μl 10×
blocking agent, 21.5 μl 2× hi-rpm buffer (Agilent
Technologies), 8 % formamide (Carl Roth), 1.2 μl mouse
Cot-1 DNA (Life Technologies, Darmstadt, Germany) were
added per tube. The mixture was incubated for 3 min at 95 °C
and subsequently for 30 min at 60 °C. Then, 40 μl of each
sample were used to hybridize the microarrays by incubation
at 67 °C with 20 rpm for 24 h. After washing and drying the
slide by centrifugation, the arrays were scanned with a High-
Resolution Microarray C Scanner (Agilent Technologies)
with a resolution of 3 μm. Data extraction was carried out
using the Feature Extraction Software (Agilent Technologies).
We evaluated our microarray data using the open source
software platform EMMA2, which has been designed for con-
sistent storage and efficient analysis of microarray data
(Dondrup et al. 2009). Normalization was carried out using
the LOWESS method (Yang et al. 2002). Normalized data was
subjected to Student's t-tests to determine significantly regulat-
ed regions with p values below a threshold of 0.05. All p values
were corrected based on the method of Benjamini and
Hochberg (1995) to account for the multiple testing situation.
As we used pooled samples of each four culture replicates in
this first experiment, no internal variance within the respective
groups was calculated. Gene ontology classifications were car-
ried out using DAVID (Huang et al. 2009) with an EASE score
≤0.01. Genes found to be differentially methylated without
butyrate addition (compare with Fig. 3b, c) were removed from
the '24 h' and '48 h' datasets before cluster analysis.
Bisulfite sequencing
The efficiency of enrichment of methylated DNAwas compared
to bisulfite sequencing experiments of promoter regions of a
positive (branched chain-amino-acid aminotransferase
cytosolic-like, Bcat1, GeneID 100763658) and a negative (β-
actin, Actb , GeneID 100689477) control. Bisulfite conversion of
500 ng genomic DNA was carried out using the Epimark
Bisulfite Conversion Kit (NEB) according to the manufacturer´s
protocol. Specific genomic regions were amplified using
Epimark Taq polymerase (NEB) and primers specific for bisulfite
converted DNA (Metabion, Martinsried, Germany). A region of
the Actb promoter was amplified with primers actb_for (5′-
GGTAAGTAGGGATAATAGGTTTAGT-3′) and actb_rev (5′-
CCCCCAAAATAAACAAATAC-3′). The Bcat1 promoter was
amplified using the primers bcat1_for (5′- GGGTGT
TAGGAATTAAATTTTTAATT-3′) and bcat1_rev (5′- CACA
ATAACTTTCTCTAAAACTCCC-3′). The primer design was
carried out using MethPrimer (Li and Dahiya 2002) and PCR
products were purified from agarose TAE (Tris-acetate EDTA)
gels using the GeneJet Gel Extraction Kit (Thermo Fisher
Scientific, Waltham, MA, USA). The purified amplicons were
cloned into pJet1.2/blunt cloning vector (CloneJet PCR Cloning
Kit; Thermo Fisher Scientific), which was subsequently
transformed into One Shot® TOP10 Chemically Competent
Escherichia coli cells (Invitrogen, Carlsbad, CA, USA). Five
clones were randomly chosen and sequenced (Sequencing Core
Facility of the Center for Biotechnology, Bielefeld University).
The sequences were compared with the original DNA sequence
using the BiQ analyzer software (Bock et al. 2005).
Quantitative real-time PCR
The efficiency of methylated DNA enrichment was deter-
mined by qPCR using the Platinum® SYBR® Green qPCR
SuperMix-UDG (Invitrogen) on a LightCycler® 480 (Roche,
Penzberg, Germany). For Actb quantification the oligonucle-
otides qActb_for (5′-CCGCGGAGCGGACACTTTCA-3′)
and qActb_rev (5′- AGCGGGTCCACCGGTGTCTA-3′)
and for Bcat1 quantification the oligonucleotides qBcat1_for
(5′- GCAGGGACGCTGTTTGGCCT-3′) and qBcat1_rev
(5′-GGCTTTCCAGGGCTCTGCGT-3′) were used.
Results
Design and establishment of a CHO-specific CGI microarray
To predict CGIs within the CHO genome, an algorithm
according to Takai and Jones (2002) was applied to the
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currently available genomic and in-house transcriptomic CHO
data (Becker et al. 2011; Xu et al. 2011). We identified a total
of 43318 CGIs in the CHO genome, 21993 of which could be
associated with promoter and intragenic regions, respectively.
Our microarray covers 19598 (89 %) of these CGIs with
27446 individual probes within a 60 K high-density format
so that each island is represented by at least two probes. This
customized microarray was then applied to examine DNA
methylation changes upon butyrate addition over time.
Figure 1a outlines the experimental procedure. Central to
our experiment is the enrichment of methylated DNA by
magnetic beads coupled MBD2-Fc protein. To verify the
success of the applied method, the enrichment efficiency
was controlled and optimized by determining the ratio be-
tween two previously identified regions in the CHO genome,
one unmethylated (β-actin, Actb ) and one methylated
(branched chain aminotransferase 1, Bcat1) (Fig. 1b). The
quantifications of these positive and negative enrichment con-
trols were performed by real-time PCR (Fig. 1c) and indicate a
more than 11,000-fold enrichment of the methylated com-
pared to the unmethylated region. The assessment of an input
comparison showed no significant differences between the
input fractions (Fig. 1d). Therefore, DNA preparations could
be regarded as sufficiently homogenous to allow direct
comparison of enriched methylated fractions along with an
application of the LOWESS normalization approach.
In a first application of our microarray the methylated DNA
fractions of each four replicate control and butyrate-treated
CHO cell cultures per sampling point were pooled, fluores-
cently labeled and hybridized to microarrays as dye swap
pairs. The LOWESS normalized data was subjected to
Student's t -tests (adjusted p <0.05) to identify significantly
differentially enriched genomic regions. Genes associated
with these regions were searched for Gene Ontology clusters
(EASE score <0.01).
Effect of butyrate addition on growth and cell specific IgG
productivity
The effect of butyrate on CHO DP-12 cell growth and pro-
ductivity is shown in Fig. 2. Twenty-four hours after butyrate
addition reduced cell growth could already be detected in
treated cultures and the viability started to decrease. The
butyrate-treated cells reached a maximum of 31×105 cells/ml
on day 5 (48 h after butyrate addition). The control cultures
continued normal cell growth until a maximum viable cell
density of 110×105 cells/ml was reached on day 7. Viabilities
as well as viable cell densities of the control cultures started to
Fig. 1 Experimental design and quality control. a Schematic represen-
tation of methylated DNA enrichment combined with the CHO-specific
CpG islandmicroarray. b Bisulfite sequencing results of the CGIs ofActb
and Bcat1. The black region represents the CGI, the black arrow marks
the transcription start site. Black circles represent a methylated CpG
position, white circles indicate unmethylated CpG positions. The red
arrows indicate the positions of primers used to control the enrichment
reaction by quantitative real-time PCR. c Diagram of fold enrichment
measured by qPCR. Values were normalized to the input concentration.
Enrichment of the methylated region was calculated setting the Actb
enrichment to one. d MA plot of the dye swapped input control
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decrease after day 7. Butyrate treatment resulted in enhanced
cell specific productivities on day 5 with a maximum value of
17 pg/cell/day, whereas the control cultures only achieved
maximum cell specific productivities of 9 pg/cell/day. This
corresponds to a 2-fold increase in IgG productivity upon
butyrate addition at this time point.
Butyrate-mediated differential CGI methylation
To investigate genome-wide differential methylation upon
butyrate addition, samples from the reference and butyrate-
treated cultures had been taken at three time points before (0 h)
as well as 1 (24 h) and 2 (48 h) days upon butyrate addition.
For each time point, pooled samples of four biological repli-
cates were analyzed. Figure 3a shows MA plots of the com-
bined four replicates of the arrays hybridized with enriched
methylated DNA. The plots indicate either hypomethylated
(M≥1.0) or hypermethylated (M≤−1.0) regions amongst all
three time points. The Venn diagrams in Fig. 3b and c illustrate
the numbers of genes associated with differentially methylated
CGIs and show that the effect of butyrate on DNA methyla-
tion was highly dynamic and reversible. We were astonished
to find 42 genes to be relatively hypermethylated and 141
genes to be relatively hypomethylated in a comparison be-
tween reference and butyrate-treated cultures even before
addition of the fatty acid. Similar numbers were seen at the
end of the experiment (32 genes affected by relative hyper-
methylation and 110 genes affected by hypomethylation). A
strongly increased number of 1221 genes associated with
differentially methylated CGIs was found 24 h after butyrate
supplementation, with 342 genes showing relative hyperme-
thylation of corresponding CGIs and 879 genes being associ-
ated with relatively hypomethylated genomic regions. The
greatest overlap in the sampling points regarding affected
genes existed between 24 and 48 h (139 genes in total).
Furthermore, 30 genes showed differential methylation both
Fig. 2 Cell growth and IgG
production of butyrate-treated and
control cultures. Shown are the
mean values of each four replicate
cultures, error bars represent
standard deviations. a Mean
viable cell density (continuous
lines) and viability (dashed
lines). Addition of 3 mM butyrate
is marked by a red vertical line,
sampling points for microarray
analyses are marked by grey
arrows . b Mean IgG titer
(continuous lines) and cell
specific productivity (dashed
lines) of butyrate and reference
cultures
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before butyrate treatment and 24 h later. Only ten genes were
found to be significantly differentially methylated amongst all
three time points, and five differentially methylated genes
were both present at 0 and 48 h.
Gene ontology analyses were carried out in order to gain an
overview of affected cellular processes and components
(Fig. 4a and b). In the dataset recorded before butyrate treat-
ment, it was found that the GO protein group 'positive regu-
lation of developmental process' was significantly overrepre-
sented. The data of sampling point '24 h' suggest that the genes
associated with hypermethylated CGIs play a role in the
processes 'response to stimulus', 'phosphorylation' and 'bio-
genesis', e.g., represented by the more specific functions
'DNA repair', 'response to organic substance' or 'programmed
cell death'. Within the group of genes associated with
hypomethylated CGIs, the categories 'transcription', 'chroma-
tin', 'signaling', 'immune response', 'developmental process'
and 'phosphate metabolism' were frequently affected, e.g.,
comprising functions such as 'regulation of gene-specific tran-
scription', 'chromatin modification', 'regulation ofMAP kinase
activity' or 'immune system development'. Another 24 h later
(sampling point '48 h'), genes related to 'carbohydrate biosyn-
thetic process' were abundantly associated with hyper-
methylated CGIs. Hypomethylated genes at the 48 h sampling
point could be clustered according to the functional categories
'chromatin modification', 'dendrite morphogenesis', 'post-
embryonic development' or 'protein modification by small pro-
tein conjugation or removal'.
Differential methylation of Wnt signaling genes
Within the genes associated with differentially methylated
CGIs 24 h upon butyrate addition, genes related to the 'intra-
cellular signaling cascade' were significantly overrepresented.
Next to MAPK- and Ca2+-signaling, one of the mainly affect-
ed cellular pathways comprised within this group was theWnt
signaling pathway (see KEGG pathway in Fig. 5). Promoter
methylation of key elements and target genes of the canonical
branch as well as the Wnt/Ca2+ pathway was detected for the
following genes: Porcn ,Wnt6 , Fzd7 , Prkx and Rbx1 showed
Fig. 3 Significantly differentially
methylated genes upon butyrate
treatment. a MA plots for the
indicated sampling points. M
values below the threshold of
−1.0 (red) represent de novo
methylated regions upon butyrate
treatment. M values above the
threshold of 1.0 (green) represent
hypomethylated regions upon
butyrate treatment. The blue lines
mark for each time point the 95 %
and 99 % confidence intervals of
all observedM values. The yellow
line represents the LOWESS fit.
b ,c Venn diagrams of genes
associated with hypermethylated
(b) or hypomethylated (c) CpG
islands prior to (0 h), 24 h and
48 h upon treatment of CHO DP-
12 cells with 3 mM butyric acid
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relatively hypermethylated CGIs located in promoter regions.
The promoters of Dvl1 , Axin , Camk2g , Lrp5 , Prkcg ,
Ppp2r5e , Ppp3cc , Tcf7l1 , Tcf7l2 and Tbl1x were detected
as relatively hypomethylated. Further examination of the data
concerning central β-catenin co-activator proteins showed
either relatively hypermethylated (Bcl9l , Pygo2 , Med13 ) or
relatively hypomethylated genes (Med1 , Trrap , Mll , Mll2).
Finally, the Wnt responsive genes Myc and cycD1 were
detected as relatively hypermethylated.
Discussion
Avariety of methods has been developed to conduct genome-
scale analyses of DNA methylation, ranging from microarray
hybridization techniques to DNA methylation profiling by
whole-genome shotgun bisulfite sequencing (WGSBS), the
latter yielding genome-wide methylation data in single-base
resolution (Bock et al. 2010). However, for economic reasons
WGSBS, although providing the greatest genome coverage, is
applicable only to a limited number of samples (Laird 2010).
Microarray-based techniques enable the analysis of a larger
number of samples, but restrict the investigations to a pre-
selected number of genomic loci. As we were interested in a
comprehensive examination of DNAmethylation changes in a
medium-throughput format, we developed a customized CHO
CGI microarray to simultaneously analyze multiple samples
of enriched methylated DNA and detect differentially meth-
ylated genomic regions. We applied our microarray to com-
pare butyrate treated with reference CHO cultures in order to
analyze the butyrate effect in CHO cells.
The stability of production cell lines can be impaired by
recombinant gene loss or malfunctioning transcriptional
events (Beckmann et al. 2012; He et al. 2012) as well as
epigenetic silencing of recombinant genes e.g., affecting the
CMV promoter (Kim et al. 2011; Osterlehner et al. 2011).
Supplementation of the SCFA butyrate leads to alterations of
epigenetic silencing events and can be used to enhance cell
specific productivities in CHO cells (Jiang and Sharfstein
2008; Boffa et al. 1978; Gorman et al. 1983; Chen et al.
2002). This is, among other yet unknown effects, due to the
inhibitory influence of butyrate on HDACs (Davie 2003). In
this context, the analysis of DNA methylation is particularly
important to gain further insight into the epigenetic response
to butyrate addition. With our work, we are now able to show
that butyrate-induced inhibition of growth and increased cell
Fig. 4 Gene ontology analysis of
genes affected by butyrate-
mediated differential methylation
of associated CpG islands. a ,b
Heat maps of significantly
enriched GO terms. GO analysis
was carried out using DAVID
with an EASE score ≤0.01. Genes
detected without treatment with
3 mM butyric acid (0 h) were
removed from the 24 and 48 h
datasets before ontology analysis.
Log2 values of fold enrichment
are colour-coded according to the
legend, n.s. not significantly
enriched
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specific productivities in anti-IL8 producing CHO DP-12
cultures is accompanied by significant and reversible changes
in DNA methylation.
Butyrate causes methylation of genes related to several
functional categories in a time-dependent manner
The analysis of differentially methylated regions showed 1221
genes to be affected 24 h upon butyrate addition. Gene ontol-
ogy analyses were carried out to obtain an overview of in-
volved cellular processes and components. One overrepre-
sented group of affected genes 24 h upon butyrate addition
was related to the 'intracellular signaling cascade'. A closer
view showed involvement of pathways such as the MAPK,
Ca2+ and the canonical Wnt/β-catenin signaling system.
Butyrate-mediated effects on these signal transduction path-
ways have been reported before in human cell lines (Yang
et al. 2001; Zhang et al. 2010) and, among others, may lead to
the observed apoptotic events and the negative impact on cell
cycle progression. A butyrate-mediated regulation of apopto-
sis, gene expression, cell cycle, transport, growth and prolif-
eration was shown on other cellular levels and in other cell
types as well (Wu et al. 2012; Yee et al. 2008; Chang et al.
2012; Zhou et al. 2011; Li and Li 2006). The presence of
components of 'neuron development', 'synaptic transmission'
or 'dendrite morphogenesis' was striking, too. Though buty-
rate is able to induce differentiation of stem cells into neural
cells (Yao et al. 2010), an involvement of such specific factors
in butyrate-treated CHO cells has not been reported yet.
Another significantly abundant group of ontologies refers to
'immune system development'. Several publications report an
anti-inflammatory effect of SCFAs, e.g., on human monocytes
(Säemann et al. 2000).
Interestingly, 48 h upon butyrate supplementation 91 % of
the observed regulations at sampling point '24 h' were not
detectable anymore. In order to investigate a possible under-
lying mechanismmore closely, the array data was subjected to
an analysis regarding regulatory components of the DNA
Fig. 5 Differential methylation of CGIs associated with genes involved
in the Wnt signal transduction system 24 h upon butyrate addition. Genes
associated with relatively hypomethylated CGIs (green ), genes
associated with relatively hypermethylated CGIs (red) and genes without
significantly differentially methylated CGIs (not coloured). Figure based
on KEGG (Kanehisa and Goto 2000)
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methylation machinery. The genes Dnmt3a and Uhrf1 , cod-
ing for major mediators of de novo and maintenance methyl-
ation (Bostick et al. 2007; Cedar and Bergman 2009), turned
out to be relatively hypomethylated at the 24 h sampling point.
Furthermore, the genes Gadd45g and Apobec2 , coding for
mediators of DNA demethylation (Barreto et al. 2007; Rai
et al. 2008) showed changes in their promoter methylation.
Strikingly, functional components of the chromatin modifying
machinery were especially affected at sampling point '48 h'.
As mentioned before, butyrate is known to inhibit HDAC
activity (Boffa et al. 1978) and to have an effect on chromatin
modification (Costa 2008). However, initially we did not
expect such highly dynamic changes on the epigenetic level
in CHO cells upon butyrate treatment. Also, we were sur-
prised to see a number of differentially methylated genes
among the cultures prior to butyrate treatment that were re-
moved from the '24 h' and '48 h' datasets before further data
analysis. These numbers and also the ratios between the
respective sampling points remain constant even after apply-
ing the most stringent statistical parameters. There are several
possible explanations for this finding. On the one hand, a
statistically relevant occurrence of differentially methylated
genes could of course be caused by a biased enrichment
reaction or uneven labeling of enriched methylated DNA.
On the other hand it is known that within cell populations or
even between individual cells a certain degree of noise can
occur within regulatory networks (Chalancon et al. 2012). It
was shown that switching between states of DNAmethylation
can contribute to this noise (Lim and van Oudenaarden 2007).
The differentially methylated genes detected before butyrate
treatment may represent this effect, which could be further
magnified by asynchronous cell growth or minimal chrono-
logical differences in sampling. Interestingly, it is known that
cultured cells can behave very differently over the course of a
production process even if they were treated in the same way
(Le et al. 2012). The reason for this differential behavior has
not been found yet. However, since in this first application of
our novel CHO CGI microarray, the two groups of four
replicates for reference and butyrate-treated cultures were
pooled after the enrichment of methylated DNA for microar-
ray analysis, the variance within this group cannot be calcu-
lated yet. Current experiments address the variance between
identically treated cultures and will furthermore allow an
estimation of putative biased experimental steps.
Differentially methylated core components of canonical
Wnt/β-catenin signaling
In order to prove the ability of our CHO-specific CGI micro-
array to detect differential methylation within central regula-
tory networks, canonical Wnt signaling as one of many af-
fected pathways was exemplarily analyzed. Wnt signaling is
mediated by the highly conserved family of secreted Wnt
glycolipoproteins and directs several developmental processes
(MacDonald et al. 2009). We detected butyrate-mediated
DNA methylation within the canonical Wnt/β-catenin path-
way ranging from members of Wnt biogenesis and signal
transduction in the cytoplasm to transcriptional regulation in
the nucleus (respective differentially methylated genes in
brackets). Porcupine (Porcn ), an ER localized membrane-
spanning protein, mediates secretion and palmitoylation of
Wnt proteins (Wnt6 ) (Hausmann et al. 2007; Janda et al.
2012). This modification is essential for their interaction with
the Frizzled seven-pass transmembrane protein family (Fzd7)
and the LDL receptor-related proteins LRP5 and LRP6 (Lrp5)
(Janda et al. 2012). The formation of a Wnt–Fzd–LRP com-
plex leads to recruitment of the scaffolding protein
Dishevelled (Dvl1 ), subsequent interaction with the Axin
complex (Axin ) and thereby stabilization of β-catenin
(Logan and Nusse 2004). β-Catenin moves into the nucleus
and regulates gene expression of Wnt target genes alongside
the transcription factors TCF/LEF (Tcf7l1 , Tcf7l2 ; Hoppler
and Kavanagh 2007). The subsequent recruitment of several
co-activators (e.g.,Med1 ,Med13 , Bcl9l orPygo2) regulates a
plethora of transcriptional events (MacDonald et al. 2009).
For example, expression of the Wnt responsive gene c-Myc
(Myc ) is activated by β-catenin (He et al. 1998). Myc has
decisive influence on growth, proliferation and differentiation
(Massagué 2004). Its expression was previously shown to be
influenced by butyrate (Krupitza et al. 1995; Mariani et al.
2003) and may be accountable for many reported effects of
butyrate as well as those we observed in CHO DP-12 cells
upon supplementation of the SCFA. Generally, the influence
of butyrate on Wnt signaling has been stated before on other
cellular levels, e.g., by measuring Wnt activity or Wnt target
gene expression upon butyrate treatment (Bordonaro et al.
2008; Shin et al. 2012). However, to our knowledge, this is
the first time that such a far-reaching influence of butyrate-
mediated DNA methylation changes on the Wnt signal trans-
duction system has been shown.
Perspectives of CHO CGI microarrays
With this work, we present the first CGI microarray that
allows the detection of differential DNA methylation in
CHO cells on a genomic scale. A comprehensive study
conducted on CHO DP-12 cells demonstrates that our newly
designed array is applicable to unravel epigenetic events in the
course of cultivation processes. In our first experiment the
effect of butyrate on DNA methylation unexpectedly turned
out to be highly dynamic and reversible. Moreover, signaling
pathways such as the MAPK-, Ca2+- and canonical Wnt/β-
catenin system were affected by differential DNA methyla-
tion. Further investigations will clarify if the observed revers-
ibility of the epigenetic effects is due to a putative feedback
mechanism or to process-related circumstances. Eventually,
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this should lead to identification of central cellular compo-
nents targeted by butyrate. Considering the different effects of
DNA methylation at certain genomic loci, the impact of
differential DNA methylation should ideally be examined by
combining DNA methylation analysis with transcriptomics,
proteomics and metabolomics in order to gain information on
multiple cellular levels. This new approach to study genome-
wide changes in DNA methylation in dependency on various
cultivation characteristics will provide valuable information
regarding the optimization of production processes. A prom-
ising application is a subsequent target selection for metabolic
and epigenetic engineering approaches. This should facilitate
the optimization of product titer and quality in recombinant
CHO cells and furthermore enable establishment of methods
to screen for stably producing cell lines.
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Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
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